安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease together
- Home | GSK US
June 12 2026 GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome June 10 2026 The Franklin Institute and GSK celebrate 40 years of GSK Science in the Summer™ with a new "Be a Chemist!"
- GSK plc - Wikipedia
GSK plc (an abbreviation of its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company [3][4] It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, [n 1] which was itself a merger of a number of pharmaceutical companies around the Smith, Kline French firm
- GSK to acquire U. S. cancer drugmaker Nuvalent for $10. 6 billion
U K pharmaceutical group GSK has entered an agreement to acquire U S -based specialist oncology biotech Nuvalent for $10 6 billion
- GSK plc (GSK) Stock Price, News, Quote History - Yahoo Finance
Find the latest GSK plc (GSK) stock quote, history, news and other vital information to help you with your stock trading and investing
- GSK makes biggest ever acquisition with $10. 6bn for US cancer drug firm
GSK took over the Swiss company’s vaccines division for $5 25bn and sold its cancer portfolio to Novartis for $16bn under its then chief executive, Andrew Witty
- GSK acquires Nuvalent for $10. 6 billion in oncology push
GSK agreed to acquire Nuvalent, a Boston-based clinical-stage biopharmaceutical company focused on lung cancer treatments, for $10 6 billion in an all-cash deal, the company said Tuesday
- GSK boosts cancer portfolio with $10. 6 billion Nuvalent takeover
GSK has agreed to buy U S -listed cancer drug developer Nuvalent for $10 6 billion in its largest deal in more than a decade, marking a strategic shift under new CEO Luke Miels as the British
|
|
|